Old Web
English
Sign In
Acemap
>
Paper
>
P1.14-14 Monitoring of EGFR Mutations During Osimertinib Treatment in Advance EGFR-Mutant T790M Positive NSCLC
P1.14-14 Monitoring of EGFR Mutations During Osimertinib Treatment in Advance EGFR-Mutant T790M Positive NSCLC
2019
Katja Mohorcic
Andrej Janzic
Urska Janzic
Mitja Rot
Izidor Kern
Keywords:
Cancer research
Pathology
Mutant
T790M
Osimertinib
Medicine
egfr mutation
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]